生物標記技術市場規模、佔有率、成長分析、按測試類型、按產品、按分析技術、按研究領域、按應用、按地區 - 行業預測，2025 年至 2032 年

2023 年全球生物標記技術市場規模價值344 億美元，預計將從2024 年的375.6 億美元成長至2032 年的759.6 億美元，預計在預測期內（2025-2032 年）的複合年成長率為1.4 %。

全球生物標記技術市場是醫療保健不可或缺的一部分，利用生物標記來評估正常和疾病過程以及治療反應。聚合酵素鏈鎖反應、次世代定序和免疫測量等關鍵技術正在被用於識別對癌症、感染疾病、自體免疫疾病等診斷至關重要的生物標記。此外，生物標記可以促進在開發過程中早期檢測藥物毒性，支持個人化醫療的努力。市場預期成長的動力在於疾病盛行率的不斷上升、研發力度的加強以及早期毒性測試的日益普及。然而，初始發現成本高以及對生物標記技術的認知低等挑戰可能會阻礙成長。相反，新興國家為未來市場擴張提供了重大機遇，也為創新生物標記應用提供了廣闊的前景。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步

生物標記技術市場規模（按測試類型分類）

• 市場概況
• 固態切片檢查
• 液態生物檢體

生物標記技術市場規模（依產品分類）

• 市場概況
• 生物標記的識別、檢驗和開發研究
  • 耗材
  • 裝置
  • 服務
  • 軟體
• 常規生物標記檢測
  • 耗材
  • 裝置
  • 服務
  • 軟體

按分析技術分類的生物標記技術市場規模

• 市場概況
• 免疫檢測
  • ELISA
  • 西方墨點法
  • 蛋白質微陣列
• PCR
• 成像技術
• 質譜分析
• 下一代種子
• 層析法
• 細胞遺傳學
• 其他分析技術

生物標記技術市場規模（依研究領域分類）

• 市場概況
• 基因組學
• 蛋白質體學
• 代謝體學
  • 代謝助焊劑
  • 脂類組學
  • 其他
• 其他研究領域

生物標記技術市場規模（按應用）

• 市場概況
• 生物標記的識別、檢驗和開發研究
• 常規生物標記檢測

生物標記技術市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific Inc.（United States）
• Bio-Rad Laboratories, Inc.（United States）
• Danaher Corporation（United States）
• Waters Corporation（United States）
• Shimadzu Corporation（Japan）
• Siemens Healthineers AG（Germany）
• Illumina, Inc.（United States）
• PerkinElmer, Inc.（United States）
• Abbott Laboratories（United States）
• Roche Holding AG（Switzerland）
• Merck KGaA（Germany）
• Becton, Dickinson and Company（United States）
• GE Healthcare（United States）
• Bruker Corporation（United States）
• Hologic, Inc.（United States）
• Myriad Genetics, Inc.（United States）
• Bio-Techne Corporation（United States）

結論和建議

Global Biomarker Technologies Market size was valued at USD 34.4 billion in 2023 and is poised to grow from USD 37.56 billion in 2024 to USD 75.96 billion by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).

The global biomarker technologies market is vital in healthcare, leveraging biological markers to evaluate normal and disease processes as well as treatment responses. Key technologies such as polymerase chain reaction, next-generation sequencing, and immunoassays are employed to identify biomarkers critical for diagnosing conditions like cancer, infectious diseases, and autoimmune disorders. Furthermore, biomarkers facilitate early detection of drug toxicity in development and support personalized medicine initiatives. Anticipated market growth is driven by rising disease prevalence, intensified R&D efforts, and increasing adoption of early toxicity testing. However, challenges including high initial discovery costs and limited awareness of biomarker technologies may impede growth. Conversely, emerging economies present significant opportunities for future market expansion, enhancing the scope for innovative biomarker applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomarker Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomarker Technologies Market Segmental Analysis

Global Biomarker Technologies Market is segmented by Test Type, Product, Profiling Technology, Research Area, Application and region. Based on Test Type, the market is segmented into Solid Biopsy and Liquid Biopsy. Based on Product, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on Profiling Technology, the market is segmented into Immunoassay, PCR, Imaging Technologies, Mass Spectrometry, NGS, Chromatography, Cytogenetics and Other Profiling Technologies. Based on Research Area, the market is segmented into Genomics, Proteomics, Metabolomics and Other Research Areas. Based on Application, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biomarker Technologies Market

Global Biomarker Technologies (GBT) leads the charge in advancing precision medicine through the discovery and validation of innovative biomarkers. Focusing on early disease detection, personalized treatment strategies, and enhanced patient monitoring, GBT develops cutting-edge diagnostics that integrate seamlessly into clinical workflows. Their proprietary technology platforms harness the power of genomics, proteomics, and metabolomics to propel research and development across various therapeutic areas, including oncology, cardiology, and neurodegenerative diseases. By fostering collaborations with academic institutions and pharmaceutical companies, GBT accelerates the translation of scientific discoveries into actionable insights, ultimately elevating the standard of care and improving patient outcomes globally.

Restraints in the Global Biomarker Technologies Market

Global Biomarker Technologies must ensure that its research and development practices adhere strictly to ethical guidelines and regulatory standards concerning patient data privacy and consent. Furthermore, the organization should prioritize diversity and inclusivity within its clinical trials to avoid bias in biomarker validation and enhance the applicability of its findings across different populations. The company must also maintain transparent communication with stakeholders about the limitations and potential risks associated with biomarker applications. Finally, Global Biomarker Technologies is encouraged to seek collaborations that foster innovation while aligning with its mission to improve healthcare outcomes globally.

Market Trends of the Global Biomarker Technologies Market

The Global Biomarker Technologies market is witnessing significant growth, propelled by a surge in personalized medicine initiatives that utilize biomarkers for tailored disease management. Advancements in genomics, proteomics, and molecular diagnostics are enhancing the identification of unique biomarkers, facilitating precise diagnosis and targeted therapeutic strategies. Additionally, there is a strong shift towards non-invasive and minimally invasive testing techniques, particularly liquid biopsies, which enhance patient comfort while improving diagnostic accuracy. This convergence of technology and personalized healthcare is fostering innovation and driving investment in biomarker research and development, positioning the market for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Biomarker Technologies Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Solid Biopsy
• Liquid Biopsy

Global Biomarker Technologies Market Size by Product & CAGR (2025-2032)

• Market Overview
• Biomarker Identification, Validation & Development Research
  • Consumables
  • Instruments
  • Services
  • Software
• Routine Biomarker-based tests
  • Consumables
  • Instruments
  • Services
  • Software

Global Biomarker Technologies Market Size by Profiling Technology & CAGR (2025-2032)

• Market Overview
• Immunoassay
  • ELISA
  • Western Blot
  • Protein Microarray
• PCR
• Imaging Technologies
• Mass Spectrometry
• NGS
• Chromatography
• Cytogenetics
• Other Profiling Technologies

Global Biomarker Technologies Market Size by Research Area & CAGR (2025-2032)

• Market Overview
• Genomics
• Proteomics
• Metabolomics
  • Metabolic Flux
  • Lipidomics
  • Others
• Other Research Areas

Global Biomarker Technologies Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biomarker Identification, Validation & Development Research
• Routine Biomarker-based tests

Global Biomarker Technologies Market Size & CAGR (2025-2032)

• North America (Test Type, Product, Profiling Technology, Research Area, Application)
  • US
  • Canada
• Europe (Test Type, Product, Profiling Technology, Research Area, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Product, Profiling Technology, Research Area, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Product, Profiling Technology, Research Area, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Product, Profiling Technology, Research Area, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations